ConductScience.org, home

Paper29486751

Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study.

Isfoss BL and 5 others. BMC Cancer, 2018. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study. Papers, record 29486751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29486751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study.
PubMed
Journal
BMC Cancer
PubMed
Year
2018
PubMed
Publication types
Journal Article, Observational Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.1
iCite
Revised in PubMed
2025-05-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Isfoss BLBjörn Logi
2Holmqvist BBo
3Sand EElin
4Forsell JJohan
5Jernström HHelena
6Olsson HHåkan

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Breast NeoplasmsMajor topic
IsoenzymesMajor topic
Mesenchymal Stem CellsMajor topic
Retinal DehydrogenaseMajor topic
Adult
Aged
Aged, 80 and over
Aldehyde Dehydrogenase 1 Family
BRCA1 Protein
BRCA2 Protein
Female
Humans
Middle Aged
Mutation
Risk Factors
Young Adult

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
294576European Research CouncilInternationalPubMed
ERC-2011-AdG 294576European Research CouncilInternationalPubMed

Source PubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110213546
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet1997https://conductscience.org/library/papers/10213546PubMed
210584720Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2.Lancet1999https://conductscience.org/library/papers/10584720PubMed
312627501Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.Cancer2003https://conductscience.org/library/papers/12627501PubMed
412927427Breast cancer and hormone-replacement therapy in the Million Women Study.Lancet2003https://conductscience.org/library/papers/12927427PubMed
514575365A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden).Cancer Causes Control2003https://conductscience.org/library/papers/14575365PubMed
616118051Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.Eur J Cancer2005https://conductscience.org/library/papers/16118051PubMed
717245541Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.Breast Cancer Res Treat2007https://conductscience.org/library/papers/17245541PubMed
817558338Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indices.Menopause2008https://conductscience.org/library/papers/17558338PubMed
918034184Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.Nat Rev Cancer2007https://conductscience.org/library/papers/18034184PubMed
1018195085Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.Physiol Rev2008https://conductscience.org/library/papers/18195085PubMed
1118371393ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.Cell Stem Cell2007https://conductscience.org/library/papers/18371393PubMed
1218611112Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily.Expert Opin Drug Metab Toxicol2008https://conductscience.org/library/papers/18611112PubMed
1318685093Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/18685093PubMed
1418805086Retinoic acid synthesis and signaling during early organogenesis.Cell2008https://conductscience.org/library/papers/18805086PubMed
1519052772Vinculin and cellular retinol-binding protein-1 are markers for quiescent and activated hepatic stellate cells in formalin-fixed paraffin embedded human liver.Histochem Cell Biol2009https://conductscience.org/library/papers/19052772PubMed
1619911270Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.Breast Cancer Res Treat2010https://conductscience.org/library/papers/19911270PubMed
1720565829Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort.Breast Cancer Res2010https://conductscience.org/library/papers/20565829PubMed
1821628574Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21628574PubMed
1922260461Distribution of aldehyde dehydrogenase 1-positive stem cells in benign mammary tissue from women with and without breast cancer.Histopathology2012https://conductscience.org/library/papers/22260461PubMed
2023175153SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers.Int J Oncol2013https://conductscience.org/library/papers/23175153PubMed

See all 38 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
35117809Selective estrogen receptor modulators in the prevention of breast cancer in premenopausal women: a review.Transl Cancer Res2020https://conductscience.org/library/papers/35117809PubMed
34670861Cancer-Associated Fibroblast Subpopulations With Diverse and Dynamic Roles in the Tumor Microenvironment.Mol Cancer Res2022https://conductscience.org/library/papers/34670861PubMed
30596083Potential protective effect of ALDH-1 stromal expression against early recurrence of operable breast cancers.Stem Cell Investig2018https://conductscience.org/library/papers/30596083PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29486751

GET https://conductscience.org/api/papers/v1/29486751/references?page=2